SOURCE: Equity News Circuit

Equity News Circuit

February 26, 2013 08:00 ET

Squawk Box Stocks Reports On: Zynga, Inc. (NASDAQ: ZNGA), Affymax, Inc. (NYSE: AFFY), 3D Systems Corp. (NYSE: DDD), Dynavax Technologies Corporation. (NASDAQ: DVAX)

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwire - Feb 26, 2013) - Zynga, Inc. (NASDAQ: ZNGA), Affymax, Inc. (NYSE: AFFY), 3D Systems Corp. (NYSE: DDD), Dynavax Technologies Corporation. (NASDAQ: DVAX).

Zynga, Inc. (ZNGA) saw shares advancing 7.52% or $0.24 per share to close yesterday at $3.43 on volume of 102,864,984 shares traded. The company has seen a sharp rise on optimism that other U.S. states may follow Nevada in legalizing real-money gambling over the Internet. With New Jersey Gov. Chris Christie set to make a decision on legalizing online gambling in the state of New Jersey this week will shares of Zynga, Inc. continue to trade higher in anticipation? Find out our thoughts in our exclusive report at:

Affymax, Inc. (AFFY) saw shares declining 85.35% or $14.10 per share to close at $2.42 on volume of 60,515,859 shares traded during Monday's trading session. Shares plummeted after the Palo Alto company and partner Takeda Pharmaceutical said they were voluntarily recalling their drug Omontys treating anemia in kidney dialysis patients. Three patients reportedly died from fatal reactions after receiving the companies' drug. Find out our thoughts on what to expect from Affymax, Inc. next in our exclusive report at:

3D Systems Corp. (DDD) saw shares declining 9.00% to close yesterday's trading session at $34.55 on volume of 15,719,626 shares traded. The 3D printer company announced fourth-quarter revenues rose 45% to $101.6 million which lagged consensus estimates for $103.9 million. Earnings per share, on a split-adjusted basis of 26 cents, were a penny above consensus estimates of analysts polled by Thomson Reuters. The 44% EPS gain was the 10th straight quarter of double- or triple-digit growth but a deceleration from the previous quarter. Will shares continue to trade lower following this lackluster earnings report or will we see the stock bounce back? Find out more in our exclusive report at:

Dynavax Technologies Corporation. (DVAX) saw shares losing 32.32% or $0.96 per share to close yesterday at $2.01 on volume of 21,9889,283 shares traded. The biopharmaceutical company saw shares slide following the receipt of a negative complete response letter from the FDA regarding its hepatitis B vaccine, Heplisav. After investors digest the news will we see a recovery in Dynavax's share price? Find out our thoughts in our exclusive report at:


Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Winning Media LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information

  • Contact Information:
    Winning Media LLC
    Email Contact